Fullerton Healthcare Corp., the medical service provider that shelved plans for a Singapore initial public offering in 2016, is now aiming to sell shares in the U.S., people with knowledge of the matter said.
The Singapore-based company is starting preparations for a U.S. IPO that could take place as soon as this year, the people said, asking not to be identified because the process is private. Fullerton Healthcare and existing investors had sought to raise as much as S$271 million ($202 million) in the city-state in 2016, before deferring the deal amid queries from regulators.
Continue reading this premium story with a subscription to DealStreetAsia.Subscribe
Already a Subscriber? Log in
Contact us for corporate subscriptions at firstname.lastname@example.org